(Q44388059)

2 December 2017

title

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs (English)

1 reference

2 December 2017

Brisson M

1

1 reference

2 December 2017

Edmunds WJ

series ordinal

2

1 reference

2 December 2017

publication date

1 September 2006

1 reference

2 December 2017

published in

Medical Decision Making

1 reference

2 December 2017

volume

26

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

434-446

1 reference

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Handling uncertainty in cost-effectiveness models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Review of guidelines for good practice in decision-analytic modelling in health technology assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Methodological issues and new developments in the economic evaluation of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Varicella vaccination in England and Wales: cost-utility analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Modelling the impact of immunization on the epidemiology of varicella zoster virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Cost-effectiveness of a routine varicella vaccination program for US children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Instituting a routine varicella vaccination program in Canada: an economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

The cost-effectiveness of varicella vaccine programs for Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

A cost benefit analysis of routine varicella vaccination in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Economic evaluations of varicella vaccination programmes: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Costs, effects and C/E-ratios alongside a clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Costs And Benefits Of Routine Varicella Vaccination In German Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

Willingness to pay and the valuation of programmes for the prevention and control of influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06290485

21 January 2018

Identifiers

DOI

10.1177/0272989X06290485

1 reference

release_dncwir24dvashbu2hfthriokou

2 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dncwir24dvashbu2hfthriokou

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference